Current Report Filing (8-k)
November 22 2016 - 6:48AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_____________________________
FORM 8-K
_____________________________
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
November 22, 2016
_____________________________
Medtronic Public Limited Company
(Exact name of Registrant as Specified in its Charter)
_____________________________
|
|
|
|
|
|
|
|
|
Ireland
|
|
1-36820
|
|
98-1183488
|
|
(State or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(IRS Employer
Identification No.)
|
|
|
|
|
|
20 On Hatch, Lower Hatch Street
Dublin 2, Ireland
|
|
(Address of principal executive offices)
|
(Registrant’s telephone number, including area code):
+353 1 438-1700
_____________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
|
|
|
|
|
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
|
|
|
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
|
|
|
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
|
|
|
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
|
|
|
|
|
|
Item 2.02.
|
Results of Operations and Financial Condition
|
On November 22, 2016, Medtronic plc, a public limited company organized under the laws of Ireland, issued a press release announcing its second quarter fiscal year 2017 financial results and posted a related earnings presentation to the Investors section of its website. A copy of the press release and related earnings presentation are furnished as Exhibits 99.1 and 99.2 to this report.
(d) List of Exhibits
|
|
|
|
|
|
|
Exhibit Number
|
|
Description
|
|
|
|
|
99.1
|
|
Press release of Medtronic plc, dated November 22, 2016
|
|
99.2
|
|
Earnings presentation, dated November 22, 2016
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MEDTRONIC PUBLIC LIMITED COMPANY
|
|
|
|
|
|
|
|
|
|
|
By
|
|
/s/ Karen L. Parkhill
|
|
Date: November 22, 2016
|
|
|
|
|
|
Karen L. Parkhill
|
|
|
|
|
|
|
|
Executive Vice President and Chief Financial Officer
|
EXHIBIT INDEX
|
|
|
|
|
|
|
Exhibit Number
|
|
Description
|
|
|
|
|
99.1
|
|
Press release of Medtronic plc, dated November 22, 2016
|
|
99.2
|
|
Earnings presentation, dated November 22, 2016
|
Medtronic (NYSE:MDT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Medtronic (NYSE:MDT)
Historical Stock Chart
From Apr 2023 to Apr 2024
